STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management will deliver a presentation on Wednesday, January 15th at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time).

Investors and interested parties can access both the live presentation and archived webcast through Absci's investor relations website at investors.absci.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

VANCOUVER, Wash. and NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Absci management is scheduled to present on Wednesday, January 15th at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time). Interested parties may access a live and archived webcast of the presentation on the company’s investor relations website at: investors.absci.com.

About Absci

Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.

Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com 

Media Contact
press@absci.com 


FAQ

When is Absci (ABSI) presenting at the 2025 J.P. Morgan Healthcare Conference?

Absci (ABSI) is scheduled to present on Wednesday, January 15th, 2025, at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time).

How can investors watch Absci's (ABSI) J.P. Morgan Healthcare Conference presentation?

Investors can watch both the live and archived webcast of Absci's presentation through the company's investor relations website at investors.absci.com.

Which healthcare conference is Absci (ABSI) participating in January 2025?

Absci is participating in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

What type of company is Absci (ABSI) described as in their conference announcement?

Absci is described as a data-first generative AI drug creation company.
Absci Corp

NASDAQ:ABSI

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

560.89M
136.27M
9.25%
60.02%
21.14%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER